Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06595953 · ClinicalTrials.gov registry record · Phase 2
Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety
A Phase 2 study of Anxiety Disorders and Psychiatric Disorders, sponsored by National Institute of Mental Health (NIMH).
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06595953: Recruiting Phase 2 study of Anxiety Disorders and Psychiatric Disorders, sponsored by National Institute of Mental Health (NIMH).
NCT06595953 is a Phase 2 study of Anxiety Disorders and Psychiatric Disorders that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 150 participants, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06595953, a Phase 2 study of Anxiety Disorders and Psychiatric Disorders, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Anxiety disorders are becoming more common among children and teenagers. Anxiety can lead to long-term physical and mental problems, such as depression. Treatments for anxiety disorders include medications as well as cognitive behavioral therapy (CBT); CBT is a form of talking therapy. Both approaches work in only about 50 percent of cases. A new approach, called gaze-contingent music reward therapy (GCMRT), may help. Objective: To find out whether GCMRT combined with CBT is more effective than CBT alone. Eligibility: Children aged 8 to 17 years with separation anxiety disorder; generalized anxiety disorder; or social anxiety disorder. They must be enrolled in protocol 01-M-0192. Design: Participants will come to the clinic once a week for 4 weeks for CBT. Sometimes the participant will meet with the doctor alone; sometimes their parent may be present. They will do some computer-based tasks: They may be asked to push a button when a target appears; they may look at pictures of faces while the computer tracks their eye movements. Participants will take questionnaires each week. They will answer questions about their anxiety symptoms, feelings, and behavior. For the next 8 weeks, participants will participate in both CBT and 1 of 2 types of GCMRT. GCMRT is a computer-based task. Participants will look at pictures with many faces in them; while they do this, pleasant music will play and stop playing over a 12-minute period. Participants will have a final visit in week 13. They will take questionnaires. They will do final research tasks. Each visit lasts about 2 hours.
Primary Outcome
Completed by the clinician.
Conditions Studied
Interventions
- BEHAVIORAL Gaze-Contingent Music Reward Therapy
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-12-04 |
| Est. Completion | 2029-10-01 |
| Phase | Phase 2 |
What NCT06595953 shows while recruiting
NCT06595953 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which Gaze-Contingent Music Reward Therapy is the first listed.
NCT06595953 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06595953 about?
NCT06595953 is a clinical study titled "Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety". Background: Anxiety disorders are becoming more common among children and teenagers. Anxiety can lead to long-term physical and mental problems, such as depression. Treatments for anxiety disorders include medications as well as cognitive behavioral therapy (CBT); CBT is a form of talking therapy. ...
What is the current status of trial NCT06595953?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2024-12-04. Estimated completion is 2029-10-01.
What conditions does trial NCT06595953 study?
This clinical trial studies the following conditions: Anxiety Disorders, Psychiatric Disorders.
What interventions are being tested in trial NCT06595953?
The interventions under investigation include: Gaze-Contingent Music Reward Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06595953?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06595953 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06595953's enrollment target sits among peer trials
150 31st of 84 higher than 51 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)
RECRUITING · Phase 2
-
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
RECRUITING · Phase 2
-
Pramipexole to Enhance Social Connections
RECRUITING · Phase 2
-
AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)
COMPLETED · Phase 2
-
Inhaled Oxytocin and HPA Axis Reactivity
COMPLETED · Phase 2
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI